Contributing Editor
- Dean & Professor of Medicine, Tufts University School of Medicine
- Chief Academic Officer, Tufts Medicine
Areas of Special Interest
- Infections in immunocompromised patients
- S. aureus infections
- Development of new anti-infective agents
Professional Recognition & Appointments
- Chair, National Institutes of Health (NIH) Antibacterial Resistance Leadership Group (ARLG) Innovations Working Group; Member, ARLG Executive and Steering Committees
- Chair (2021-2026) and Member (2014-2021), Board of Trustees of The College of the Holy Cross
- Member, Board of the Physicians of Tufts Medical Center
- Elected Treasurer, Infectious Diseases Society of America (IDSA)
- Former Editor of Antimicrobial Agents and Chemotherapy
- Editor of Infectious Diseases Clinics of North America
- Former Chief, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center
- Former Director, Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance (Levy CIMAR)
- IDSA Society Citation Award (2015)
- Voting Member, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (2015)
- Maxwell Finland Award (2022)
- Honorary Fellow, Royal College of Physicians of Ireland (2023)
- Fellow, American Society for Microbiology (2026)
Publication Highlights
Numerous peer-reviewed scientific articles, textbook chapters, reviews and scientific abstracts including:
- U.S. Efforts to Curb Antibiotic Resistance-Are We Saving Lives? N Engl J Med - 2020
- Antibiotic Development Incentives that Reflect Societal Value of Antibiotics. Clin Infect Dis - 2020
- Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process. JAMA - 2020
- The Infectious Diseases Society of America's 10 x '20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 x '20 a Possibility? Clin Infect Dis - 2019
- Partial Oral Therapy for Osteomyelitis and Endocarditis - Is It Time? N Engl J Med - 2019
- Sequential, Multiple-Assignment, Randomized Trials for Comparing Personalized Antibiotic Strategies (SMART-COMPASS). Clin Infect Dis - 2019
- Drug-Use and Post-Operative Mortality Following Valve Surgery for Infective Endocarditis: A Systematic Review and Meta-Analysis. Clin Infect Dis - 2019
- A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections. Clin Infect Dis - 2019
Education
- College of the Holy Cross (B.A.)
- University of Texas Medical School at Houston (M.D.)
- Deaconess Hospital (Residency, Chief Resident)
- Beth Israel Deaconess Medical Center (Fellowship)
Disclosures
- Nothing to disclose